Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

Reports Net Revenues of $170.5 Million for the Three Months Ended March 31, 2025 RANCHO CUCAMONGA, CA / ACCESS Newswire / May 7, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three …
Jetzt den vollständigen Artikel lesen